Metastatic Breast Cancer With Intracranial Metastases Clinical Trial Using cabazitaxel and lapatinib

- The folks at SCRI Development Innovations, LLC are studying the effects of cabazitaxel; lapatinib on Metastatic Breast Cancer With Intracranial Metastases in individuals ages 18 years and older. This clinical trial is slated to start November 2013 and is expected to end circa March 2016.

877-691-7274
Denise A. Yardley, MD
Overall Study Contact Info
StatusName Contact Phone
RecruitingDenise A. Yardley, MDasksarah@scresearch.net877-691-7274

This study is officially titled, "Phase II Study With Lead-in Safety Cohort of Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases."

Locations

Florida Cancer Specialists - South

Fort Myers, Florida - Recruiting

Florida Cancer Specialists-North

St. Petersburg, Florida - Recruiting

Tennessee Oncology

Nashville, Tennessee - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.